Rademikibart IV for Acute Asthma and COPD Exacerbation | MicrobiomeTrials← Back to trialsNCT07705737
Rademikibart IV for Acute Asthma and COPD Exacerbation
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-08-21Est. Completion: 2026-12
Enrollment target: 40 participants Locations- Columbus Clinical Services, LLC, Miami, Florida, United States
- Pharmax Research of South Florida, Inc., Miami, Florida, United States
- Washington University- Cardiovascular Imaging and Clinical Research Core Laboratory, St Louis, Missouri, United States
Other microbiome trials you might be interested in
AsthmaAsthma in ChildrenAllergyRhinitis, AllergicAtopic DermatitisAllergen Immunotherapy
The summary is available at --\> https://www.finnatopy.fi/summary
Tampere, FinlandCompleted Dec 2032
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)
This observational study aims to evaluate the long-term effectiveness and safety of mepolizumab 300 mg/4 weeks in adults…
Florence, ItalyCompleted Mar 31, 2026